These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6853671)

  • 1. Radioactive iodine in the treatment of medullary carcinoma of the thyroid.
    Saad MF; Guido JJ; Samaan NA
    J Clin Endocrinol Metab; 1983 Jul; 57(1):124-8. PubMed ID: 6853671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioiodine in the treatment of hereditary medullary carcinoma of the thyroid.
    Nieuwenhuijzen Kruseman AC; Bussemaker JK; Frölich M
    J Clin Endocrinol Metab; 1984 Sep; 59(3):491-4. PubMed ID: 6746863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients.
    Saad MF; Ordonez NG; Rashid RK; Guido JJ; Hill CS; Hickey RC; Samaan NA
    Medicine (Baltimore); 1984 Nov; 63(6):319-42. PubMed ID: 6503683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The medullary (C-cell) carcinoma of the thyroid. A therapeutic dilemma].
    Schumann J; Hauk H; Leonhardi B
    Chirurg; 1977 Oct; 48(10):666-70. PubMed ID: 913180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodine as an adjunct to the surgical treatment of medullary thyroid carcinoma.
    Deftos LJ; Stein MF
    J Clin Endocrinol Metab; 1980 May; 50(5):967-8. PubMed ID: 7372781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients.
    Samaan NA; Schultz PN; Haynie TP; Ordonez NG
    J Clin Endocrinol Metab; 1985 Feb; 60(2):376-80. PubMed ID: 3965495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of thyroid carcinoma with radioactive 131I.
    Paryani SB; Chobe RJ; Scott W; Wells J; Johnson D; Kuruvilla A; Schoeppel S; Deshmukh A; Miller R; Dajani L; Montgomery CT; Puestow E; Purcell J; Roura M; Sutton D; Mallett R; Peer J
    Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):83-6. PubMed ID: 8823262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioactive iodine treatment in medullary thyroid carcinoma.
    Faik Erdogan M; Gursoy A; Erdogan G; Kamel N
    Nucl Med Commun; 2006 Apr; 27(4):359-62. PubMed ID: 16531922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioiodine in the treatment of medullary carcinoma of the thyroid.
    Hellman DE; Kartchner M; Van Antwerp JD; Salmon SE; Patton DD; O'Mara R
    J Clin Endocrinol Metab; 1979 Mar; 48(3):451-5. PubMed ID: 429497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.
    Grünwald F; Menzel C; Fimmers R; Zamora PO; Biersack HJ
    J Nucl Med; 1996 Dec; 37(12):1962-4. PubMed ID: 8970514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer.
    Saint-Vil D; Emran MA; Lambert R; Alos N; Turpin S; Huot C
    J Pediatr Surg; 2007 May; 42(5):853-6. PubMed ID: 17502198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prospective therapy study in differentiated thyroid carcinoma].
    Gemsenjäger E; Heitz P; Martina B
    Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differentiated thyroid carcinoma in children and adolescents: therapeutic strategy according to clinic presentation].
    Causeret S; Lifante JC; Borson-Chazot F; Varcus F; Berger N; Peix JL
    Ann Chir; 2004; 129(6-7):359-64. PubMed ID: 15297226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective study.
    Ceccarelli C; Bencivelli W; Morciano D; Pinchera A; Pacini F
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3512-5. PubMed ID: 11502772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of radioiodine in management of thyroid cancer: experience with 70 cases.
    Afroz S; Ahmed K; Yasmeen S; Ahmed F; Nisa L
    Bangladesh Med Res Counc Bull; 1992 Dec; 18(2):68-71. PubMed ID: 1303083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
    Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
    Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
    Mazzaferri EL; Kloos RT
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1490-8. PubMed ID: 11932270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of low doses of 131I to ablate residual thyroid tissue following surgery for thyroid cancer.
    Kuni CC; Klingensmith WC
    Radiology; 1980 Dec; 137(3):773-4. PubMed ID: 7444061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoassay of human calcitonin in serum and tissue from healthy individuals and patients with medullary carcinoma of the thyroid gland.
    Gautvik KM; Normann T; Teig V; Wille SO; Brennhovd IO; Christensen I
    Scand J Clin Lab Invest; 1976 Jul; 36(4):323-9. PubMed ID: 959750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.